If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
345.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.116%)
Market Cap: £2.52b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate change

13 May 2026 16:12

RNS Number : 2188E
TP ICAP Group plc
13 May 2026
 

 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

13 May 2026

 

TP ICAP Group plc (the 'Company' or 'TP ICAP')

 

Director Changes

 

The Company is pleased to announce the appointment of Jane Guyett and Paul Newman as Independent Non-executive Directors of the Company. Jane's appointment will be effective from 1 July 2026 and Paul's appointment effective from 1 August 2026. On joining the Board Jane will assume the role of Chair of the Remuneration Committee and join the Audit Committee. Paul will join the Risk Committee and be the EMEA Workforce Engagement Director. Both Jane and Paul will join the Nominations & Governance Committee.

 

Jane is currently the Senior Independent Director at Hiscox Group, a Non-Executive Director at Royal London Mutual Insurance Society ('Royal London') and BDO LLP. She Chairs the Remuneration Committees for Hiscox and Royal London and the Risk Oversight Committee at BDO. The majority of Jane's executive career was spent at Bank of America, where she served in leadership roles including COO for Global Markets EMEA & Asia.

 

Paul brings over 40 years of experience in capital markets, wholesale broking, and commodity derivatives. He spent more than 25 years at ICAP plc, where he founded the firm's commodities arm in 1990 and served as Executive Managing Director, and subsequently Chair of ICAP Energy until 2016, and as Chair of ICAP Shipping from 2008 to 2014. He was a director at NEX Group plc from 2016 until its acquisition by CME Group in 2018.

Commenting on Jane and Paul's appointments, Richard Berliand, Chair of TP ICAP Group plc, said:

 

"We are very pleased to welcome both Jane and Paul to the Board of the Company. They both bring substantial capital markets, broking and securities experience from their respective executive career and directorship roles, and each will be a great addition to our Board."

 

The Company also announces that Tracy Clarke and Mark Hemsley, Independent Non-executive Directors, will stand down as Directors of the Company with effect from 30 June 2026. Commenting on their future departure, Richard Berliand, said:

 

"The Board would like to thank both Tracy and Mark for their significant contribution to the Board during their tenure. The insights, challenge, and advice that they have been able to bring to the debate is much appreciated".

 

This announcement is made in accordance with UK Listing Rules 6.4.8R and there are no other additional matters that require disclosure under Listing Rule 6.4.6.

 

 

 

ENDS

 

For further information, please contact:

 

Victoria Hames

Company Secretariat

Email: CompanySecretarial@tpicap.com

 

Derek Brown

Head of Investor RelationsDirect: +44 (0) 20 3933 0447

Email: Derek.brown@tpicap.com

 

Richard Newman

Group Head of Marketing and Communications

Direct: +44 (0) 7469 039 307

Email: Richard.Newman@tpicap.com

 

About TP ICAP Group plc

 

TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

We are the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFFQELFBBB
Date   Source Headline
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20254:45 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20254:30 pmRNSHolding(s) in Company
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:05 amRNSLaunch of fourth share buyback programme of £30m
11th Mar 20257:00 amRNSFinal Results
6th Mar 20254:35 pmRNSHolding(s) in Company
13th Feb 20258:00 amRNSHolding(s) in Company
10th Feb 20254:30 pmRNSHolding(s) in Company
23rd Jan 20255:30 pmRNSDirectorate Change
17th Jan 20252:45 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 202410:21 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20244:15 pmRNSHolding(s) in Company
13th Nov 20243:00 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:05 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.